Drug Profile
IMD 1
Alternative Names: IMD1; Incrementally modified drug 1Latest Information Update: 30 Mar 2015
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Antihypertensives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertension